All posts tagged
10 Hot European Biotechs to Observe in 2017 🚀
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
The 8 Biggest Biotech Medical Fails of 2016 in Europe
What does ‘Anti-Aging Treatment’ mean in Biotech?
Evotec closes the year partnering with Celgene to treat Alzheimer’s
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
Meet the first Biotech to jump on Autophagy after this years’ Nobel Prize
World Mental Health Day: How is Biotech Helping the Cause?
Another “Almost” against Alzheimers: Lundbeck’s Phase III Flop
UPDATE: AC Immune rakes in €52.5M IPO for assault on Alzheimers
French Biotech that makes Drugs faster and cheaper IPO’s for €31M
Labiotech UG, All Rights Reserved -
Send this to friend